185 related articles for article (PubMed ID: 37249826)
1. A review on the role of NDRG1 in different cancers.
Ghafouri-Fard S; Ahmadi Teshnizi S; Hussen BM; Taheri M; Sharifi G
Mol Biol Rep; 2023 Jul; 50(7):6251-6264. PubMed ID: 37249826
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic but non-essential role of N-myc downstream regulated gene 1 in the progression of esophageal squamous cell carcinoma.
Wei W; Bracher-Manecke JC; Zhao X; Davies NH; Zhou L; Ai R; Oliver L; Vallette F; Hendricks DT
Cancer Biol Ther; 2013 Feb; 14(2):164-74. PubMed ID: 23192272
[TBL] [Abstract][Full Text] [Related]
3. Increased NDRG1 expression is associated with advanced T stages and poor vascularization in non-small cell lung cancer.
Fan C; Yu J; Liu Y; Xu H; Wang E
Pathol Oncol Res; 2012 Jul; 18(3):549-56. PubMed ID: 20853080
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
Ando T; Ishiguro H; Kimura M; Mitsui A; Kurehara H; Sugito N; Tomoda K; Mori R; Takashima N; Ogawa R; Fujii Y; Kuwabara Y
Dis Esophagus; 2006; 19(6):454-8. PubMed ID: 17069588
[TBL] [Abstract][Full Text] [Related]
5. NDRG1 overexpression promotes the progression of esophageal squamous cell carcinoma through modulating Wnt signaling pathway.
Ai R; Sun Y; Guo Z; Wei W; Zhou L; Liu F; Hendricks DT; Xu Y; Zhao X
Cancer Biol Ther; 2016 Sep; 17(9):943-54. PubMed ID: 27414086
[TBL] [Abstract][Full Text] [Related]
6. GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: their correlation with therapeutic outcome of neoadjuvant chemotherapy.
Ueki S; Fujishima F; Kumagai T; Ishida H; Okamoto H; Takaya K; Sato C; Taniyma Y; Kamei T; Sasano H
BMC Cancer; 2020 Feb; 20(1):161. PubMed ID: 32106831
[TBL] [Abstract][Full Text] [Related]
7. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH
Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595
[TBL] [Abstract][Full Text] [Related]
8. N-myc downstream-regulated gene 1/Cap43 may function as tumor suppressor in endometrial cancer.
Lv XH; Chen JW; Zhao G; Feng ZZ; Yang DH; Sun WW; Fan JS; Zhu GH
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1703-15. PubMed ID: 22678098
[TBL] [Abstract][Full Text] [Related]
9. NDRG1/Cap43 overexpression in tumor tissues and serum from lung cancer patients.
Wang D; Tian X; Jiang Y
J Cancer Res Clin Oncol; 2012 Nov; 138(11):1813-20. PubMed ID: 22722710
[TBL] [Abstract][Full Text] [Related]
10. NDRG1 expression is related to the progression and prognosis of gastric cancer patients through modulating proliferation, invasion and cell cycle of gastric cancer cells.
Chang X; Xu X; Ma J; Xue X; Li Z; Deng P; Zhang S; Zhi Y; Chen J; Dai D
Mol Biol Rep; 2014 Sep; 41(9):6215-23. PubMed ID: 24985974
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of NDRG1 predicts poor outcome and facilitates disease progression by influencing the EMT process in bladder cancer.
Li A; Zhu X; Wang C; Yang S; Qiao Y; Qiao R; Zhang J
Sci Rep; 2019 Mar; 9(1):5166. PubMed ID: 30914736
[TBL] [Abstract][Full Text] [Related]
12. A prolyl-hydroxylase inhibitor, ethyl-3,4-dihydroxybenzoate, induces cell autophagy and apoptosis in esophageal squamous cell carcinoma cells via up-regulation of BNIP3 and N-myc downstream-regulated gene-1.
Han B; Li W; Sun Y; Zhou L; Xu Y; Zhao X
PLoS One; 2014; 9(9):e107204. PubMed ID: 25232961
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA CCAT2 promotes hepatocellular carcinoma proliferation and metastasis through up-regulation of NDRG1.
Liu Y; Wang D; Li Y; Yan S; Dang H; Yue H; Ling J; Chen F; Zhao Y; Gou L; Tang P; Huang A; Tang H
Exp Cell Res; 2019 Jun; 379(1):19-29. PubMed ID: 30922920
[TBL] [Abstract][Full Text] [Related]
14. The role of NDRG1 in the pathology and potential treatment of human cancers.
Bae DH; Jansson PJ; Huang ML; Kovacevic Z; Kalinowski D; Lee CS; Sahni S; Richardson DR
J Clin Pathol; 2013 Nov; 66(11):911-7. PubMed ID: 23750037
[TBL] [Abstract][Full Text] [Related]
15. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.
Cheng J; Xie HY; Xu X; Wu J; Wei X; Su R; Zhang W; Lv Z; Zheng S; Zhou L
Cancer Lett; 2011 Nov; 310(1):35-45. PubMed ID: 21763068
[TBL] [Abstract][Full Text] [Related]
16. Correlation between NDRG1 and PTEN expression in endometrial carcinoma.
Chen J; Li S; Yang Z; Lu G; Hu H
Cancer Sci; 2008 Apr; 99(4):706-10. PubMed ID: 18377423
[TBL] [Abstract][Full Text] [Related]
17. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
[TBL] [Abstract][Full Text] [Related]
18. Growth differentiation factor-15: a p53- and demethylation-upregulating gene represses cell proliferation, invasion, and tumorigenesis in bladder carcinoma cells.
Tsui KH; Hsu SY; Chung LC; Lin YH; Feng TH; Lee TY; Chang PL; Juang HH
Sci Rep; 2015 Aug; 5():12870. PubMed ID: 26249737
[TBL] [Abstract][Full Text] [Related]
19. Association of NDRG1 gene promoter methylation with reduced NDRG1 expression in gastric cancer cells and tissue specimens.
Chang X; Zhang S; Ma J; Li Z; Zhi Y; Chen J; Lu Y; Dai D
Cell Biochem Biophys; 2013 May; 66(1):93-101. PubMed ID: 23099645
[TBL] [Abstract][Full Text] [Related]
20. The up-regulation of NDRG1 by HIF counteracts the cancer-promoting effect of HIF in VHL-deficient clear cell renal cell carcinoma.
Zhang ZY; Zhang SL; Chen HL; Mao YQ; Li ZM; Kong CY; Han B; Zhang J; Chen YH; Xue W; Zhai W; Wang LS
Cell Prolif; 2020 Jul; 53(7):e12853. PubMed ID: 32537867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]